Improving maternal nutrition status is foundational for healthy and strong families, communities, and economically self-reliant countries.
Thus, HMHB’s advocacy efforts are directed towards increasing investments and triggering policy change to adopt and scale maternal nutrition interventions, specifically MMS and reach mothers across low-and middle-income countries (LMICs) and other poor resource settings who have inadequate access to nutrient-rich diets.
In 2021 the World Health Organization decided to include MMS on the WHO Essential Medicine List, following a joint evidence-based submission by the Micronutrient Forum and the New York Academy of Sciences (NYAS) in 2020.
HMHB and the MMS-Technical Advisory Group have developed an Advocacy Brief and Frequently Asked Questions document (FAQ) to support nutrition and public health professionals to advocate for the inclusion of MMS in national EMLs.
Historically, collective efforts within the global development sector have been directed largely to child nutrition. The Nutrition Year of Action 2021 offered an opportunity to drive new nutrition commitments and investments, specifically targeting women and mothers, and highlight MMS as one of the most cost-effective interventions in global development leading to enormous human capital gains.
The HMHB Consortium’s advocacy-related efforts include: